Skip to nav Skip to content

Clinical Trial Search

363 Clinical Trials Found

Clinical Trial 22540

A Phase 1, open-label, multicenter, first-in-human study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary anti-tumor activity of VVD-130037, a Kelch-like ECH-associated protein 1 (KEAP1) activator, in participants with advanced solid tumors
Disease Site: Lung
PI: Chiappori, Alberto

Clinical Trial 22617

Disease Site: Breast
PI: Soyano Muller, Aixa

Clinical Trial 23082

Disease Site: Melanoma, skin
PI: Karapetyan, Lilit

Clinical Trial 23154

Disease Site: Other
PI: Sallman, David

Clinical Trial 23208

Disease Site: Soft Tissue
PI: Komrokji, Rami

Clinical Trial 23226

Disease Site: Leukemia, other, Myeloid and Monocytic Leukemia
PI: Mishra, Asmita

Clinical Trial 23652

A Phase 1, multicenter, open-label study of UB-VV111 in combination with rapamycin in relapsed/refractory (R/R) CD19+ hematologic malignancies
Disease Site: Hodgkin's Lymphoma, Lymphoid Leukemia, Non-Hodgkin's Lymphoma
PI: Shah, Bijal

Clinical Trial 23335

Disease Site: Multiple Myeloma
PI: Nguyen, Nina

Clinical Trial 23369

Disease Site: Other
PI: Grogan, Patrick

Clinical Trial 23454

Disease Site: Soft Tissue
PI: Gaballa, Sameh

Clinical Trial 23563

A Phase 1b trial of Teclistamab in Combination with Iberdomide for Relapsed/Refractory Multiple Myeloma
Disease Site: Multiple Myeloma
PI: Grajales-Cruz, Ariel

Clinical Trial 23556

A Phase 1 Study of MLN7243 (TAK-243) for Either Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome/Chronic Myelomonocytic Leukemia Refractory to Hypomethylating Agents
Disease Site: Acute Leukemia (ALL, AML), Myelodysplastic syndrome (MDS)
PI: Lancet, Jeffrey